Literature DB >> 3627459

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

M L Vazquez, H Jung, J Sotelo.   

Abstract

Treatment with praziquantel for neurocysticercosis frequently induces adverse reactions due to acute destruction of parasites; these reactions are suppressed by dexamethasone therapy. However, there is controversy about the most appropriate regimen with praziquantel and dexamethasone. We studied plasma levels of praziquantel in eight patients given the drug alone or with dexamethasone. Plasma levels of praziquantel were 50% lower in the same patient when dexamethasone was given simultaneously. Dexamethasone should not be added to praziquantel therapy as preventive treatment, but should be reserved for transient therapy of adverse reactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3627459     DOI: 10.1212/wnl.37.9.1561

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  High-dose praziquantel with cimetidine for refractory neurocysticercosis: a case report with clinical and MRI follow-up.

Authors:  T Yee; J A Barakos; R T Knight
Journal:  West J Med       Date:  1999-02

2.  Bioavailability of praziquantel increases with concomitant administration of food.

Authors:  N Castro; R Medina; J Sotelo; H Jung
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Dexamethasone increases plasma levels of albendazole.

Authors:  H Jung; M Hurtado; M T Medina; M Sanchez; J Sotelo
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

4.  Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen.

Authors:  H Jung; R Medina; N Castro; T Corona; J Sotelo
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

5.  Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

Authors:  J Sotelo; O H del Brutto; P Penagos; F Escobedo; B Torres; J Rodriguez-Carbajal; F Rubio-Donnadieu
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

6.  Katayama fever: an acute manifestation of schistosomiasis.

Authors:  J F Doherty; A H Moody; S G Wright
Journal:  BMJ       Date:  1996-10-26

Review 7.  Corticosteroid use in neurocysticercosis.

Authors:  Theodore E Nash; Siddhartha Mahanty; Hector H Garcia
Journal:  Expert Rev Neurother       Date:  2011-08       Impact factor: 4.618

8.  Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel?

Authors:  Hector H Garcia
Journal:  Expert Rev Anti Infect Ther       Date:  2008-06       Impact factor: 5.091

9.  Effect of prednisone on the pharmacokinetics of the integrase inhibitor dolutegravir.

Authors:  Ivy H Song; Julie Borland; Shuguang Chen; Paul Savina; Amanda F Peppercorn; Stephen Piscitelli
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

10.  Diagnosis and treatment of neurocysticercosis.

Authors:  Christina M Coyle; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.